| Joshua Andrew Keller, MD | |
|
51 Sewall St, Portland, ME 04102-2643 | |
| (207) 774-5761 | |
| Not Available |
| Full Name | Joshua Andrew Keller |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 10 Years |
| Location | 51 Sewall St, Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578975439 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD21587 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| York Hospital | York, ME | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rheumatology Associates P.a. | 5395793541 | 7 |
| York Hospital | 6406766781 | 169 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Entity Name | Stephens Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346299815 PECOS PAC ID: 8921990193 Enrollment ID: O20040602000734 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376528398 PECOS PAC ID: 6406766781 Enrollment ID: O20040812001065 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Entity Name | Rheumatology Associates P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003098252 PECOS PAC ID: 5395793541 Enrollment ID: O20050105000221 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073527388 PECOS PAC ID: 9335043967 Enrollment ID: O20050401000844 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Andrew Keller, MD 51 Sewall St, Portland, ME 04102-2643 Ph: (207) 774-5761 | Joshua Andrew Keller, MD 51 Sewall St, Portland, ME 04102-2643 Ph: (207) 774-5761 |
News Archive
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.
The Supreme Court will hear arguments on the legality of drug companies paying their generic-making counterparts to keep generic drugs - in this case, a testosterone gel - off the market.
Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease.
› Verified 7 days ago
Andrew J. Hsu, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 155 Fore River Pkwy, Portland, ME 04102 Phone: 207-535-1100 Fax: 207-879-8787 | |
David A Polisner, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Dr. Elizabeth A Jacobs, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Brian D Moore, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Marc Stuart Hoffman, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3265 | |
Janet D Mcculley, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4618 | |
Saeeda Fatima, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St Rm 2227, Portland, ME 04102 Phone: 207-662-4618 |